Bryan M. Reasons Insider Trading $REPH Recro Pharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Bryan M. Reasons.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Bryan M. Reasons. Bryan M. Reasons is Chief Financial Officer in IMPAX LABORATORIES INC ($IPXL) and Director in Aclaris Therapeutics, Inc. ($ACRS) and EVP & CFO in Mallinckrodt plc ($MNK) and Director in Recro Pharma, Inc. ($REPH) and CFO in Amneal Pharmaceuticals, Inc. ($AMRX).
Bryan M. Reasons in Recro Pharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bryan M. Reasons: Director
Holdings: 67,429 shares
Current Value: $542,803
Latest Transaction: Apr 22 2021
$REPH Market Capitalization: $98.40M
$REPH Previous Close: $8.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Bryan M. Reasons in Recro Pharma, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACRS, AMRX, IPXL, MNK, REPH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22 2021 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Option Exercise | A | 1.71 | 38,012 | 65,001 | 38,012 | |
| Apr 22 2021 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Grant | A | 0.00 | 26,923 | 0 | 67,429 | 40.5 K to 67.4 K (+66.47 %) |
| May 11 2020 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Option Exercise | A | 8.37 | 12,405 | 103,830 | 12,405 | |
| May 11 2020 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Grant | A | 0.00 | 8,363 | 0 | 40,506 | 32.1 K to 40.5 K (+26.02 %) |
| Dec 09 2019 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Grant | A | 0.00 | 9,156 | 0 | 32,143 | 23 K to 32.1 K (+39.83 %) |
| May 10 2019 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Option Exercise | A | 8.80 | 10,888 | 95,814 | 10,888 | |
| May 10 2019 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Grant | A | 0.00 | 7,955 | 0 | 22,987 | 15 K to 23 K (+52.92 %) |
| May 14 2018 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Option Exercise | M | 0.00 | 8,849 | 0 | 0 | |
| May 14 2018 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Option Exercise | M | 0.00 | 8,849 | 0 | 0 | |
| May 14 2018 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Buy | M | 0.00 | 8,849 | 0 | 15,032 | 6.2 K to 15 K (+143.12 %) |
| May 14 2018 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Buy | M | 0.00 | 8,849 | 0 | 15,032 | 6.2 K to 15 K (+143.12 %) |
| May 08 2018 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Option Exercise | A | 11.32 | 5,742 | 64,999 | 5,742 | |
| May 08 2018 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Grant | A | 0.00 | 6,183 | 0 | 6,183 | 0 to 6.2 K |
| Mar 06 2017 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Option Exercise | A | 7.63 | 20,000 | 152,600 | 20,000 |
Page: 1